Introduction
During embryogenesis, hematopoietic and vascular lineages arise from extraembryonic and lateral plate mesoderm, derivatives of the posterior and mid regions of the primitive streak (PS) respectively 1 . In mouse embryos, the PS appears at embryonic day 6.25 and early stages of mesoderm induction can be tracked by monitoring the expression of key transcription factors such as Brachyury 2 
and
Mixl1, 3, 4 or cell surface molecules like Flk-1 and platelet derived growth factor receptor alpha (PDGFRα). 5, 6 Given that the in vitro differentiation of human embryonic stem cells (hESCs)
recapitulates aspects of vertebrate development 7 it is not surprising that, analogous to the mouse, genes such as BRACHYURY, MIXL1, KDR (the human Flk-1 homologue)
and PDGFRα, are expressed during the in vitro mesoderm differentiation of hESCs. 8, 9 Hemangioblasts, common hematovascular progenitors that emerge from the posterior PS in the mouse embryo, 10 also appear in cultures of differentiating mouse 11 and human 8, 9 ESCs after 2-4 days and are followed by the later emergence of primitive erythroid cells, macrophage and other myeloid and lymphoid lineages. [12] [13] [14] [15] We have established an in vitro hESC differentiation system to study the development of early hematopoietic mesoderm in a defined, serum-free medium, showing that exogenously added TGFβ family molecules induce primitive streak-like cells that subsequently differentiate into blood. [16] [17] [18] To assist in these studies, we modified a hESC line by inserting GFP into the locus of the MIXL1 homeobox gene (MIXL1 GFP/w ), thus enabling identification and isolation of viable, PS-like, cells. and its cognate receptor (APLNR) in the PS of the mouse embryo. 21 Isolated APLNR + cell populations were enriched in hemangioblast colony forming cells (BL-CFCs), as also shown in a recent report. 13 We extended these prior observations by showing that APLNR expression was also observed in MIXL1 + cells representing the anterior primitive streak, a region harbouring cells fated to become dorsal mesoderm and endoderm. 8, [22] [23] [24] Furthermore, we showed that APLN enhanced the growth of embryoid bodies (EBs), increased the frequency of hemangioblast colonies and synergized with VEGF to increase growth of endothelial cells. Collectively, our study demonstrates that APLN is a growth factor that can promote hematopoietic differentiation of hESCs and suggests a hitherto unrecognized role for the APLN/APLNR axis in the regulation of early human hematopoiesis.
Methods

Cell culture and differentiation
The HES3, 25 MEL1 (Millipore, MA), H9 (WiCell Research Institute, WI) and
MIXL1
GFP/w HES3 8 hESC lines were passaged and differentiated as spin embryoid bodies (EBs) in APEL medium 16, 17 supplemented with the following growth factor combinations: 100ng/ml fibroblast growth factor (FGF) 2; BVS (30ng/ml bone For personal use only. on October 28, 2017. by guest www.bloodjournal.org From morphogenetic protein (BMP) 4, 30ng/ml vascular endothelial growth factor (VEGF), 40ng/ml stem cell factor (SCF)); B lo VSA hi (5ng/ml BMP4, 30ng/ml VEGF, 40ng/ml SCF, 100ng/ml ACTIVIN A); BV hi S (40ng/ml BMP4, 50ng/ml VEGF, 25ng/ml SCF); BVSA (20ng/ml BMP4, 30ng/ml VEGF, 40ng/ml SCF, 20ng/ml ACTIVIN A) and BVSW (30ng/ml BMP4, 30ng/ml VEGF, 40ng/ml SCF, 100ng/ml Wnt3a).
BMP4, FGF2, VEGF and SCF were purchased from PeproTech and ACTIVIN A from R&D Systems. In some cultures 50ng/ml APELIN-13 pyroglutamate (APLN) (Sigma-Aldrich) was added. Work on human embryonic stem cells was approved by the Monash University Human Research Ethics Committee.
To identify Bl-CFCs, dissociated day (d)3 EBs were cultured at 5-10 x 10 3 cells/well in serum-free MethoCult (StemCell Technologies) or in a formulation denoted MC-APEL (1% Methylcellulose in APEL medium). MethoCult cultures were supplemented with 30ng/ml VEGF, 50ng/ml SCF and 3U/ml erythropoietin with or without 50ng/ml APLN, whilst 10ng/ml FGF2 was also added to MC-APEL cultures to facilitate the efficient generation of Bl-CFCs.
To bias differentiation towards hematopoiesis, after 4 days in BVS, EBs were cultured in fresh medium with 20ng/ml BMP4, 50 ng/ml VEGF, 50 ng/ml SCF, 10ng/ml FGF2 and 30 ng/ml insulin-like growth factor (IGF) 2. 
Immunofluorescence of adherent cells cultured from hemangioblast colonies
Hemangioblast colonies generated from d3 EBs were grown for 4 days in methylcellulose and individual colonies replated onto gelatinized plates in medium with 30ng/ml VEGF, 50ng/ml SCF and 3U/ml erythropoietin with or without 50ng/ml APLN. To assess LDL uptake, adherent cells were incubated overnight with 10µg/ml 
Gene-expression analysis
Selected microarray data were validated by quantitative real-time PCR using RNA extracted from the same samples as used for microarray analysis. Samples harvested at indicated time points during endoderm differentiation were also analyzed by realtime PCR. Taqman gene expression probes (Applied Biosystems) are shown in Table   S1 . Relative gene expression levels were calculated as described. 
Results
The APLNR is highly expressed during mesendodermal differentiation
Previous studies in both mouse and human ESCs demonstrated that induction of MIXL1 expression during the early stages of mesoderm differentiation was followed by the reciprocal downregulation of E-CAHERIN (E-CAD) and upregulation of platelet-derived growth factor receptor alpha (PDGFRα) expression. 8 Figure 1F ). The increased expression of APLNR in selected cell fractions was confirmed by quantitative (real-time) RT-PCR ( Figure S1 ).
APLN binds mesodermal and endodermal progenitors in differentiating hESCs
We used two independent and complementary methods to evaluate the expression of (Figure 2A ), based on the previously reported ability of radio-iodinated APLN-13 to bind APLNR + human endothelial and cardiac cells. 30 We empirically determined the optimal duration of APLN-13-Fl incubation prior to disaggregation of the embryoid bodies to were also APLNR + ( Figure S3 ). This double positive population was retained until d6
in BVS treated cultures but APLNR was rapidly downregulated after d4 in high ACTIVIN A containing cultures. These data relating to APLNR expression pattern are in accordance with mouse in situ hybridization studies, where APLNR probes labeled the whole primitive streak and adjacent mesoderm but not the endoderm.
Consistent with our earlier results
8
, anterior mesendoderm cells expressed MIXL1 at a higher intensity and for a more prolonged duration ( Figure S3 ).
Hemangioblast colony forming cells express APLNR.
The earliest hematopoietic precursors, hemangioblast colony forming cells (Bl-CFC), generate both hematopoietic cells and endothelium. 11 They are detected after 2 to 4 days of hESC differentiation, 9 and we have previously shown that most Bl-CFCs are contained in a MIXL1 + PDGFRα + fraction of the population. 8 Considering the high levels of APLNR expression in d3 EBs, we examined the frequency of Bl-CFC in flow-sorted populations from BVS and B lo VSA hi treated cultures ( Figure 3A , B). The differentiation potential of these colonies is shown in Figure 6 and Supplemental This group included mesodermal markers such as PDGFRα and a number of the HOXB cluster genes ( Figure 3D and ( Figure 3E and Table S4 Figure   S4 ). These data suggested that this protocol supported the emergence of both pancreatic and hepatic lineages. Although differentiation of the sorted fractions was less efficient than whole EBs, endodermally differentiated Ep -AR + cells also expressed both pancreatic and hepatic genes ( Figure S4 ). These results supported our microarray findings that the expression of APLNR marks both posterior and anterior streak populations.
APLN influences EB size and morphology
To explore the role of APLNR signaling during differentiation, we investigated the effect of APLN addition on hESC differentiation to mesoderm. Spin EBs were differentiated in medium supplemented with BVS, with APLN added on d2, to coincide with the earliest expression of APLNR ( Figure S3 ). In the presence of APLN, EBs were consistently larger and developed prominent thin walled 'cysts' that were seldom observed in EBs formed in BVS alone ( Figure 4A-C) . We confirmed the growth promoting effect of APLN during mesoderm differentiation with two independent hESC lines ( Figure 4D and Figure S5 ). The increased cell numbers might have resulted from increased cell proliferation and/or a decrease in programmed cell death, given that APLN influences both processes.
32,33
APLN increases hematopoietic gene expression
To determine the changes in gene expression accompanying the addition of APLN to the culture medium, we compared the transcriptional profiles of hESCs differentiated in BVS with those of cells that also received a single pulse of APLN at d2 of Figure S6 and Table S8 ).
The earliest upregulated genes included NKD1 (naked cuticle homolog 1), an antagonist of WNT signaling, and the pan-cardiac transcription factor NKX2-5 ( Figure   4F ). We observed peak expression of transcription factors expressed in hematoendothelial development from d4 -d5, including EGR1, GFI1, GATA2, MYC, LYL1, MYB and SOX18 ( Figure 4G-H) . Genes involved in angiogenesis that were also upregulated in response to APLN included CDH5, NOSTRIN, ICAM2, PECAM1, CD34, CD44 and VASH1 (Figure 4 , Figure S6 and Table S8 ). Upregulation of the smooth muscle markers TAGLN and TAGLN2 suggested a role for APLN in the generation of other mesodermal components of the vascular wall ( Figure 4 and Table   S8 ). At d5 and d6 there was a peak in the expression of genes associated with hematopoiesis that included the heme synthesis gene ALAS2, embryonic and fetal globins (HBZ, HBA2, HBE1, HBG1) and TESC, a calcium binding protein required for megakaryocytic development from human hematopoietic cells. 34 These results suggested that major effects of APLN involved the regulation of both blood and endothelial differentiation genes.
APLN augments hematopoiesis
We complemented these gene expression studies by comparing mesodermal and hematopoietic lineage markers on hESC differentiated in BVS with or without APLN from day 2 of differentiation. In order to bias differentiation towards hematopoiesis, d4 EBs were cultured in fresh medium with BMP4, VEGF, SCF, FGF2 and IGF2, Figure 6H and Figure S11 ).
The demonstration that most hemangioblast colonies generated hematopoietic cells,
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From endothelium and smooth muscle is reminiscent of a similar tripotential Bl-CFC isolated from the early mouse embryo. 10 As far as we are aware, tripotential differentiation has not previously been documented for human Bl-CFCs.
When colony forming assays were performed using human CD34 + cord blood cells, the addition of APLN did not alter colony frequency or morphology, consistent with our finding that APLNR was not expressed on CD34 + cord blood cells ( Figure S12 ).
APLN enhances the endothelial growth and hematopoietic colony forming potential of d6 CD34
br KDR br cells
Both APLNR and APLN are highly expressed in endothelial precursors of the nascent vasculature and play a role during angiogenesis in regulating blood vessel diameter.
35-
38 Therefore we investigated the expression of APLNR and APLN during the differentiation of endothelial progenitors from hESCs.
Cells co-expressing high levels of CD34 and KDR are enriched for endothelial progenitors in adults 39 and endothelial progenitors from differentiating hESCs also express high levels of CD34 40 and KDR (MC, EGS and AGE, unpublished results).
The APLNR was expressed in CD34 
Discussion
We have defined a novel role for APLN, the peptide ligand for the APLNR, during the in vitro hematopoietic differentiation of hESCs. 49 In another study, Aplnr -/-mice displayed reduced water intake and were unable to concentrate urine in response to water deprivation. 43 To date, no hematopoietic phenotype has been reported in surviving Apln -/-or Aplnr -/-mice. As such, it is possible that other signaling systems operating during the critical period of hematopoietic progenitor specification are able to compensate for loss of both APLN and it receptor. In this context, given that APLN synergized with VEGF in promoting endothelial cell growth from hESCs, it would be of interest to examine the effect of APLNR signaling loss under conditions in which VEGF signaling was compromised.
In conclusion, our observations indicate a previously unrecognized role for APLNR signaling in regulating hematopoiesis in differentiating hESCs. Early hematopoietic progenitors express APLNR and the inclusion of APLN peptide in culture media enhances the efficiency of blood cell formation from differentiating hESCs. It is tempting to speculate that APLN might play a role in the generation of hematopoietic cells from endothelium, given the documented expression of APLNR in AGM vasculature on the mouse embryo. 38 The molecular cascades downstream of APLN/APLNR signaling that mediate these hematopoietic effects remain to be elucidated.
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